Rheinmetall AG

2021 — Fiscal year (FY2021)

Rheinmetall closed the year with record consolidated sales of €5,658m, operating result of €594m and an order backlog of €24.5bn, with a proposed dividend of €3.30 per share [13]. Investors viewed the company as a profitable, growing industrial group spanning defence and civilian programs, with improving margins and a rising backlog supporting sustained growth [13], [15]. The chart reflected a constructive uptrend as earnings expansion and backlog growth restored confidence [13].

Feb–Jun 2022 — Russia's invasion of Ukraine and German defence pivot

Russia's February 2022 invasion triggered a sharp policy shift in Germany, including a one‑off €100bn Bundeswehr special fund and elevated long‑term defence spending, which sharply increased expected procurement across NATO states [57], [51], [52]. Defence names were rapidly re‑rated; Rheinmetall shifted from being viewed as a cyclical supplier to a primary structural beneficiary of European rearmament, with expectations of large, multi‑year orders [37], [39]. The stock broke out in Feb–Mar 2022 as markets priced in sustained, outsized order flow [39], [37].

2022 — Record operating performance and accelerating orders

The company delivered a strong year with material sales and earnings improvement and a rapidly rising backlog as governments replenished stocks [40], [36]. Perception hardened into a "must‑own" growth theme, with Rheinmetall positioned as Europe's ammunition and land‑systems hub, investors expecting sustained top‑line and margin expansion [36], [37]. The stock sustained its uptrend through 2022 as order visibility improved and analysts upgraded outlooks [37].

2023 — Framework agreements and Ukraine production plans

Rheinmetall won multiple large framework agreements and call‑offs for 155mm artillery ammunition and other systems, including a Bundeswehr framework with potential ~€1.2bn gross volume, received sizable Ukraine‑directed orders and announced plans to produce armored vehicles and munitions locally for Ukraine [7], [2], [12], [3]. The market narrative shifted to Rheinmetall as a strategic partner to Ukraine with durable, multi‑year revenue visibility, though investor focus widened to execution risk and the timing of call‑offs [3], [11]. The rally continued with episodic consolidations as the market weighed execution risk against backlog strength [7], [2].

Mar 2024 — FY2023 results and 2024 guidance

FY2023 figures disclosed a record backlog with management guidance pointing to continued strong sales and earnings growth; the company stated 2024 sales were expected to exceed €10bn for the first time, driven by major orders across ammunition, combat vehicles and air defence [1], [9]. This reinforced the growth narrative, with investors treating Rheinmetall as a high‑visibility beneficiary of NATO rearmament; optimism on scale and margin expansion increased alongside scrutiny of industrial ramp capacity [1], [9]. The stock broke out to multi‑year highs as guidance validated elevated expectations [1], [4].

Jul 2024 — Q2 results and large order intake

Q2 2024 operating profit more than doubled year‑on‑year; the company reported very large order intake in the quarter, including ~€11.4bn in orders, and announced contracts to establish ammunition production capacity in Ukraine [4], [42], [10]. Strong earnings and order announcements were seen as proof points justifying prior re‑ratings, though attention to capex, working capital and political complexity grew [4], [10]. Sharp rally episodes around results and order announcements accompanied elevated intraday volatility as investors digested order timing and capex needs [4].

Mid‑2024 → Jan 2025 — Expansion and strategic partnerships

The company announced plans to expand production with new factories in Ukraine, Lithuania and Germany and struck strategic cooperation and JV agreements, notably a 50:50 land‑systems JV with Leonardo on MBT/IFV development and involvement in KNDS‑related project structures; a shareholder agreement for the MGCS project company was signed in Jan 2025 [10], [26], [22], [31]. Perception evolved toward Rheinmetall as a pan‑European integrator and industrial partner with longer‑term revenue upside, while investors increasingly discounted integration, regulatory and geopolitical execution risks [10], [26], [31]. The stock continued its steep uptrend through 2024; by early‑2025 it showed signs of topping with elevated volatility as the complexity and timing of large projects became central to sentiment [26], [31].

2025 — Peak backlog and reassessment

Public and media reporting showed backlog estimates at very high levels, variously cited in the €48–€55bn range as programmes matured; simultaneously, late‑2025 reports of progress toward diplomatic resolution and budget pressures in some purchaser countries prompted profit‑taking across defence names [45], [46], [62], [41]. The market moved from unconditional momentum to a valuation and timing debate, with investors focused on when framework orders would convert to revenue and cash, and on political and budget risks that could delay call‑offs [41], [62], [46]. Price action became range‑bound to rolling over with increased drawdowns on negative news about order phasing or geopolitical de‑escalation; volatility rose [41].

2026 — Reassessment and higher volatility

Across 2026 media and analysts documented a broader reassessment of European defence winners as investors re‑examined order timing, backlog conversion and budgetary constraints; coverage described a "reality check" on previously frothy valuations [38], [47]. The long‑term structural rearmament case remained intact, but short‑to‑medium‑term visibility was judged less certain — the story shifted from pure momentum growth to a valuation and timing case requiring clearer delivery metrics [47], [38]. The stock corrected from earlier peaks with episodic relief rallies; the trading profile transitioned from momentum‑led to mean‑reversion and event‑driven volatility [38], [47].